Current Perspectives on Left Ventricular Geometry in Systemic Hypertension

Area of Science:

• Cardiology
• Hypertension Research
• Cardiovascular Imaging

Background:

• Hypertension (HTN) is a major global health issue and a primary risk factor for cardiovascular disease (CVD) mortality.
• Hemodynamic stress from HTN induces left ventricular (LV) remodeling, leading to abnormal LV geometry (e.g., concentric remodeling, LV hypertrophy).
• LV geometric abnormalities are independent risk factors for CVD and serve as key outcomes in anti-HTN drug trials.

Purpose of the Study:

• To review the intricate relationship between hypertension and left ventricular geometric changes.
• To focus on the diagnostic strategies, epidemiology, pathophysiology, and prognostic impact of these changes.
• To examine the effects of anti-hypertensive therapy on LV geometry and subsequent CVD risk reduction.

Main Methods:

• Literature review of studies investigating hypertension and left ventricular geometry.
• Analysis of diagnostic approaches, including imaging techniques.
• Synthesis of epidemiological data, pathophysiological mechanisms, and prognostic implications.
• Evaluation of clinical trial data on anti-hypertensive treatments and LV remodeling.

Main Results:

• Hypertension is consistently linked to significant alterations in left ventricular geometry.
• LV geometric abnormalities are established independent predictors of cardiovascular events.
• Anti-hypertensive medications demonstrate efficacy in reversing or preventing adverse LV remodeling.
• Therapeutic interventions targeting LV geometry contribute to CVD risk reduction.

Conclusions:

• Hypertension-induced left ventricular geometric changes are critical determinants of cardiovascular risk.
• Accurate diagnosis and monitoring of LV geometry are essential in hypertensive patients.
• Effective anti-hypertensive therapy plays a vital role in mitigating LV remodeling and improving cardiovascular outcomes.